vincent cassone
STEMCats End Spring Semester Strong with Research
trra223
In the fall of 2014, a group of 235 incoming students became the first class of STEMCats at the University of Kentucky. This week, they are not only wrapping up their first year at UK
Biology Professor Helps Bring New York-based Alzheimer’s, Parkinson’s Therapeutics Company to Lexington
brconn2
Gismo Therapeutics Inc., a New York-based biotech startup, has recently relocated its company to the University of Kentucky Advanced Science and Technology Commercialization Center, a business incubator housing new and emerging technology-based companies on UK’s campus.